Dr. Alok Kumar is working as 'Associate Researcher' under Prof. Tasuku Honjo (Nobel Prize, Medicine, 2018) at Kyoto University. His work on the 'Mechanism of unresponsiveness to the PD-1 blockade therapy' is internationally recognized. He obtained his master degree (M.Sc. Biotechnology) from a very reputed 'Indian Institute of Technology Roorkee, India'. During his master studies, he worked on multi-drug resistant gram negative bacteria and generated a combinatorial cocktail to inhibit their growth.

Dr. Alok Kumar Research Interests are cancer biology; immunology; T cell biology; cancer immunotherapy; checkpoint blockade therapy (PD-1, CTLA-4)